GSK343
-
Catalog number2281-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name1-Isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridine-4-yl)-1H-indazole-4-carboxamide
-
DescriptionA potent histone H3-lysine 27 (H3K27) methyltransferase EZH2 inhibitor (IC₅₀ = 4 nM). Diplays 1000-fold selectivity for other HMTs except EZH1 (60-fold selectivity). GSK343 inhibits H3K27 methylation in HCC1806 cells with an IC₅₀ of
-
Structure AvailableYes
-
Peptide sequenceNo
-
Salt FormNo
-
Molecular FormulaC₃₁H₃₉N₇O₂
-
Molecular Weight541.69
-
Cell PermeableYes
-
Purity≥99% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from light and moisture
-
Tag LineA potent EZH2 inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID71268957
-
SMILESCCCC1=C(CNC(=O)C2=C3C=NN(C(C)C)C3=CC(=C2)C2=CC=NC(=C2)N2CCN(C)CC2)C(=O)NC(C)=C1
-
InChiInChI=1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40)
-
InChi KeyULNXAWLQFZMIHX-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameGSK343
-
Alternative nameGSK343
-